Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $368.7K | $847.3K | $1.8M | $2.3M | $3.6M | $6.4M | $3.1M |
| Operating income | −$1.4M | −$1.8M | −$3.2M | −$6.9M | −$9.5M | −$12.4M | −$20.1M |
| EBITDA | −$1.0M | −$2.2M | $457.3K | −$6.9M | −$9.5M | −$12.4M | $24.8K |
| Net income | −$1.2M | −$2.4M | −$3.0M | −$8.5M | −$9.3M | −$12.2M | −$35.9M |
| Net margin | — | — | — | — | — | — | — |
| EPS (diluted) | -0.10 | -0.21 | -0.30 | -0.75 | -7.14 | -9.41 | -1.12 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds HILS.
No tracked institution reports a position in HILS as of their last filing.
No one on the platform has traded HILS yet.
| $4M |
| — |
| GRTSGritstone bio, Inc. | $0.03 | -31.78% | $4M | — |
| NBRVFNabriva Therapeutics plc | $0.00 | +0.00% | $323 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.